As revealed in previous studies by us and others, TGF-β elicits cytostatic G1 arrest in HCC cells, mainly through two synergistic mechanisms, (1) the increased expression of specific CDK inhibitors, and (2) the repression of growth promoting factors [64,65]. Here, TGFB1 is linked to hepatocellular carcinoma.